Sensiquant

A sensitive and effective method for the monitoring of minimal residual disease in CML patients and for the detection and quantification of the main variants of BCR-ABL fusion genes.

These products are based on One-Step technology: cDNA synthesis and related quantification take place in one step.

• SensiQuant p210 Master Mix (SQT-027): for qualitative and quantitative analysis of BCR / ABL p210 transcripts (M-bcr b3a2/b2a2)
• SensiQuant p190 Master Mix (SQT-028): for qualitative and quantitative analysis of BCR / ABL p190 transcripts (m-bcr e1a2)
• PhilaREF –RNA Standard Reference (SRF-027): RNA reference aligned to WHO standard for the calculation of the conversion factor in International Scale (IS) and for Quality control procedures for the translocation BCR / ABL p210 (M-bcr b3a2 / b2a2)
• SensiQuant b3a3/b2a3 Master Mix (SQT-042): for qualitative and quantitative analysis of the rare variant BCR/ABL p210 (M-bcr b3a3/b2a3)
• SensiQuant e1a3 Master Mix (SQT-041): for qualitative and quantitative analysis of the rare variant BCR/ABL p190 (m-bcr e1a3)
• SensiQuant p230 (u-BCR) Master Mix (SQT-040): for qualitative and quantitative analysis of the rare variant BCR/ABL p230 (u-bcr e19a2/e19a3)